AstraZeneca PLC

Monday’s least-battered European stocks offer clues to safe havens for investors

1:33 p.m. Feb. 24, 2020

- Barbara Kollmeyer

European stocks struggle as coronavirus cases rise and German growth stagnates

5:21 a.m. Feb. 14, 2020

- Barbara Kollmeyer

AstraZeneca profit misses forecasts and warns outlook hinges on COVID-19

2:56 a.m. Feb. 14, 2020

- Carlo Martuscelli

AstraZeneca to discontinue Epanova trial following disappointing data

2:27 a.m. Jan. 13, 2020

- Adriano Marchese

Why Bank of America expects the hot European pharmaceuticals sector to stumble — and it’s not a fear of U.S. drug prices

7:26 a.m. Jan. 7, 2020

- Steve Goldstein

There’s more upside for biotech even after 24% gains in two months

7:06 p.m. Dec. 15, 2019

- Michael Brush

Basking in the glow of a luxury-goods deal, Burberry boosts London stocks

10:04 a.m. Nov. 25, 2019

- Barbara Kollmeyer

FTSE 100 sees biggest jump since July as weak data results knock pound

9:17 a.m. Nov. 22, 2019

- Barbara Kollmeyer

European stocks rise modestly as manufacturing data surveys remain downbeat

5:33 a.m. Nov. 22, 2019

- Barbara Kollmeyer

AstraZeneca and Daimler lead European stocks higher on day of earnings onslaught

10:43 a.m. Oct. 24, 2019

- Steve Goldstein

British pound falls as attention turns to EU and possible Brexit extension

10:35 a.m. Oct. 24, 2019

- Steve Goldstein

Brexit hopes sends British pound to highest level of Johnson administration as U.K. banks soar

8:29 a.m. Oct. 12, 2019

- Steve Goldstein

Brexit stockpiling shows up in manufacturing data and bakery results

5:13 a.m. Oct. 1, 2019

- Steve Goldstein

U.K. stocks snap three-day losing run

11:46 a.m. Sept. 19, 2019

- Steve Goldstein

Pound tumbles as British factory output hits seven-year low ahead of Brexit showdown

6:30 a.m. Sept. 2, 2019

- Callum Keown

European stocks nudge higher despite fresh U.S.-China tariffs coming into force

4:49 a.m. Sept. 2, 2019

- Callum Keown

Sainsbury continues climb from 30-year low as FTSE 100 edges higher

5:17 a.m. Aug. 20, 2019

- Steve Goldstein

Miners and pharmaceutical giants inject life into London markets

6:11 a.m. July 25, 2019

- Callum Keown

London markets fall as Italy worries spread

5:20 a.m. May 28, 2019

- Dave Morris

Italian stocks send Europe screeching into reverse

5:16 a.m. May 28, 2019

- Dave Morris

Roche’s Immunotherapy Drug Extended Patients’ Lives

9:20 p.m. Dec. 7, 2017

- The Wall Street Journal Interactive Edition

In U.K., Barriers Rising Against Foreign Deals

9:28 a.m. May 11, 2015

- The Wall Street Journal Interactive Edition

Celgene Profit Surges, Driven by Revlimid Sales

7:18 a.m. April 30, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Reports Fall in First-Quarter Profit

7:26 a.m. April 24, 2015

- The Wall Street Journal Interactive Edition

Billion-Dollar Health Startups

4:21 p.m. Feb. 27, 2015

- The Wall Street Journal Interactive Edition

Valeant to Buy Salix for About $10 Billion

8:44 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

New Cancer Technology Cheers Investors

3:35 p.m. Feb. 23, 2015

- The Wall Street Journal Interactive Edition

Valeant Nears Deal to Buy Salix

1:58 p.m. Feb. 22, 2015

- The Wall Street Journal Interactive Edition

Actavis Changing Name to Allergan

11:24 a.m. Feb. 18, 2015

- The Wall Street Journal Interactive Edition

Pharma Must Launch Itself Back

7:17 p.m. Feb. 16, 2015

- The Wall Street Journal Interactive Edition

Corporate Watch: News Digest

11:42 p.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca Deals Up a Tricky 2015

11:55 a.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

Pfizer to Buy Hospira for $16 Billion

10:22 a.m. Feb. 6, 2015

- The Wall Street Journal Interactive Edition

Astra to Buy Actavis Portfolio

6:54 a.m. Feb. 5, 2015

- The Wall Street Journal Interactive Edition

New Outsourcing Frontier in India: Monitoring Drug Safety

10:20 p.m. Feb. 2, 2015

- The Wall Street Journal Interactive Edition

AstraZeneca to Harness Benefits of Genome-Editing Technology

6:06 a.m. Jan. 29, 2015

- The Wall Street Journal Interactive Edition

Pfizer Sales Hit by Stronger Dollar

9:53 p.m. Jan. 27, 2015

- The Wall Street Journal Interactive Edition

Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug

5:07 p.m. Jan. 26, 2015

- The Wall Street Journal Interactive Edition

Peter Wallenberg Dies at 88

3:26 p.m. Jan. 19, 2015

- The Wall Street Journal Interactive Edition

Pharma Grows Itself a New Challenge -- Overheard

6:51 p.m. Jan. 13, 2015

- The Wall Street Journal Interactive Edition